HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paula Vähäsalo Selected Research

Disease Susceptibility (Diathesis)

12/2009Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paula Vähäsalo Research Topics

Disease

9Juvenile Arthritis (Juvenile Idiopathic Arthritis)
03/2023 - 09/2011
8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2023 - 01/2003
3Infections
07/2015 - 01/2003
2Pain (Aches)
11/2023 - 01/2023
2Inflammation (Inflammations)
12/2021 - 01/2012
2Autoimmune Diseases (Autoimmune Disease)
01/2018 - 03/2015
2Arthritis (Polyarthritis)
01/2018 - 01/2012
1Fatigue
11/2023
1Necrosis
03/2023
1Rheumatoid Arthritis
01/2023
1Common Variable Immunodeficiency
01/2022
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2022
1Lymphopenia (Lymphocytopenia)
01/2022
1Thyroid Diseases (Thyroid Disease)
12/2021
1Anemia
12/2021
1Papilloma (Papillomatosis)
12/2021
1Liver Diseases (Liver Disease)
12/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2021
1Genetic Predisposition to Disease (Genetic Predisposition)
12/2020
1Osteitis
01/2016
1Injection Site Reaction
07/2015
1Fever (Fevers)
01/2014
1Disease Susceptibility (Diathesis)
12/2009
1Enterovirus Infections
01/2003

Drug/Important Bio-Agent (IBA)

8AutoantibodiesIBA
01/2023 - 01/2003
41,3-di(4-imidazolinophenoxyl)propaneIBA
12/2020 - 01/2003
3Prostaglandins AIBA
11/2023 - 01/2018
2ametantrone (HAQ)IBA
11/2023 - 01/2023
2Methotrexate (Mexate)FDA LinkGeneric
03/2023 - 11/2022
2Antirheumatic Agents (DMARD)IBA
03/2023 - 01/2012
2veltuzumabIBA
12/2021 - 01/2018
1Etanercept (Enbrel)FDA Link
03/2023
1Tumor Necrosis Factor InhibitorsIBA
03/2023
1Rheumatoid FactorIBA
01/2023
1Anti-Citrullinated Protein AntibodiesIBA
01/2023
1Infliximab (Remicade)FDA Link
11/2022
1Sulfasalazine (Azulfidine)FDA LinkGeneric
11/2022
1Proteins (Proteins, Gene)FDA Link
06/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Immunoglobulin M (IgM)IBA
01/2022
1HLA-DR Antigens (HLA-DR)IBA
01/2020
1tocilizumab (atlizumab)FDA Link
01/2020
1Genetic Markers (Genetic Marker)IBA
01/2017
1Diphosphonates (Bisphosphonates)IBA
01/2016
1Analgesics (Analgesic Drugs)IBA
01/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016
1Alanine Transaminase (SGPT)IBA
07/2015
1Anti-Bacterial Agents (Antibiotics)IBA
03/2015
1Insulin (Novolin)FDA Link
12/2009
1AntigensIBA
12/2009
1islet cell antibodyIBA
01/2003
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2003
1AntibodiesIBA
01/2003
1HLA-DQB1 antigen (HLA DQB1)IBA
01/2003

Therapy/Procedure

4Therapeutics
03/2023 - 01/2012
1Combination Drug Therapy (Combination Chemotherapy)
09/2011
1Drug Therapy (Chemotherapy)
09/2011